{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T22:21:03Z","timestamp":1768602063885,"version":"3.49.0"},"reference-count":29,"publisher":"American Chemical Society (ACS)","issue":"1","license":[{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:00:00Z","timestamp":1765324800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"funder":[{"DOI":"10.13039\/100007052","name":"Memorial Sloan-Kettering Cancer Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007052","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol. Pharmaceutics"],"published-print":{"date-parts":[[2026,1,5]]},"DOI":"10.1021\/acs.molpharmaceut.5c01101","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T05:12:11Z","timestamp":1765343531000},"page":"319-328","source":"Crossref","is-referenced-by-count":0,"title":["Syntheses, Biological and Preclinical Evaluations, and Nanoparticle Formulations of the ROS-Activatable Prodrugs of Doxazolidine for Drug-Resistant Cancer Therapy"],"prefix":"10.1021","volume":"23","author":[{"given":"Ryo","family":"Tamura","sequence":"first","affiliation":[{"name":"Molecular Pharmacology Program","place":["New York, United States"]},{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-9385","authenticated-orcid":true,"given":"Jan","family":"Grimm","sequence":"additional","affiliation":[{"name":"Molecular Pharmacology Program","place":["New York, United States"]},{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, United States"]},{"name":"Department of Pharmacology","place":["New York, United States"]},{"name":"Weill Cornell Medical College","place":["New York, United States"]},{"name":"Department of Radiology","place":["New York, United States"]},{"name":"Memorial Sloan Kettering Cancer Center","place":["New York, United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"316","published-online":{"date-parts":[[2025,12,10]]},"reference":[{"issue":"6","key":"ref1\/cit1","first-page":"670","volume":"19","author":"Weiss R. B.","year":"1992","journal-title":"Semin. Oncol."},{"key":"ref2\/cit2","doi-asserted-by":"publisher","DOI":"10.1002\/bit.260110607"},{"key":"ref3\/cit3","unstructured":"National Cancer Institute https:\/\/www.cancer.gov\/about-cancer\/treatment\/drugs\/doxorubicinhydrochloride."},{"key":"ref4\/cit4","doi-asserted-by":"publisher","DOI":"10.1007\/128_2007_4"},{"key":"ref5\/cit5","doi-asserted-by":"publisher","DOI":"10.1021\/jm960519z"},{"key":"ref6\/cit6","doi-asserted-by":"publisher","DOI":"10.1021\/jm960835d"},{"key":"ref7\/cit7","doi-asserted-by":"publisher","DOI":"10.1021\/jm970739s"},{"key":"ref8\/cit8","doi-asserted-by":"publisher","DOI":"10.1021\/jm970237e"},{"key":"ref9\/cit9","doi-asserted-by":"publisher","DOI":"10.1021\/jm049496b"},{"key":"ref10\/cit10","doi-asserted-by":"publisher","DOI":"10.1021\/jm0495226"},{"key":"ref11\/cit11","doi-asserted-by":"publisher","DOI":"10.1021\/jm0303305"},{"key":"ref12\/cit12","doi-asserted-by":"publisher","DOI":"10.1021\/jm030352r"},{"key":"ref13\/cit13","doi-asserted-by":"publisher","DOI":"10.1021\/jm070569b"},{"key":"ref14\/cit14","doi-asserted-by":"publisher","DOI":"10.1021\/jm050678v"},{"key":"ref15\/cit15","doi-asserted-by":"publisher","DOI":"10.1021\/jm060597e"},{"key":"ref16\/cit16","doi-asserted-by":"publisher","DOI":"10.1021\/jm7011479"},{"key":"ref17\/cit17","doi-asserted-by":"publisher","DOI":"10.1021\/jm900694z"},{"key":"ref18\/cit18","doi-asserted-by":"publisher","DOI":"10.1021\/jm300714p"},{"key":"ref19\/cit19","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jmedchem.8b01508"},{"key":"ref20\/cit20","doi-asserted-by":"publisher","DOI":"10.1002\/adtp.202400340"},{"key":"ref21\/cit21","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-0961-y"},{"key":"ref22\/cit22","doi-asserted-by":"publisher","DOI":"10.1111\/cas.15068"},{"key":"ref24\/cit24","doi-asserted-by":"publisher","DOI":"10.3390\/ph13090205"},{"key":"ref25\/cit25","doi-asserted-by":"publisher","DOI":"10.1021\/jacs.9b04272"},{"key":"ref26\/cit26","unstructured":"MAYO CLINIC https:\/\/www.mayoclinic.org\/drugs-supplements\/ibuprofen-oral-route\/description\/drg-20070602."},{"key":"ref27\/cit27","unstructured":"National Institutes of Health https:\/\/www.techtransfer.nih.gov\/tech\/tab-4031."},{"key":"ref28\/cit28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0804773105"},{"key":"ref29\/cit29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-019-2081-4"},{"key":"ref30\/cit30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0081162"}],"container-title":["Molecular Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c01101","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.molpharmaceut.5c01101","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:35:19Z","timestamp":1768563319000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/acs.molpharmaceut.5c01101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,10]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,5]]}},"alternative-id":["10.1021\/acs.molpharmaceut.5c01101"],"URL":"https:\/\/doi.org\/10.1021\/acs.molpharmaceut.5c01101","relation":{},"ISSN":["1543-8384","1543-8392"],"issn-type":[{"value":"1543-8384","type":"print"},{"value":"1543-8392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,10]]}}}